FGF7 and cholangiocarcinoma: Additionally, STC1 encodes a secreted glycoprotein reported as a potential serum biomarker for hepatitis B virus-associated liver fibrosis51, and secreted FGF7 protein53 was identified as a prognostic marker in cholangiocarcinoma.